Syncom Formulation (India) Ltd

NSE: SYNCOMF · BSE: 524470 · Pharmaceuticals & Biotechnology · 22 announcements

Share price: ₹23.22
Market cap: ₹2,183 Cr
Revenue (annual): ₹489.2 Cr
Net profit (annual): ₹76.44 Cr
P/E (TTM): 25.5×Sector 47.4×
Promoter holding: 50.57%+0.00% QoQ
FII holding: 0.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 8 Financial Results 3 Board Meeting Date 2 Annual General Meeting 2 Results Update 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 May 2026 18:01 IST BSE

Capacity Expansion

Syncom Formulation (India) Capacity Expansion: ₹57.26 Cr Investment

Syncom Formulations (India) Limited has completed the acquisition of a commercial property in Mumbai from HDFC Bank Ltd for ₹57.26 Crore. The purchase involves the entire 7th Floor of Trade Star, Andheri-Kurla Road. This material acquisition was funded as a full and final consideration for the asset.

Value: ₹57.26 Cr

Read the filing ↗